You just read:

U.S. PTO Issues Notice of Allowance for Patent using TB4 for Improving Neurological Outcomes After Injury and Neurodegenerative Disease

News provided by

RegeneRx Biopharmaceuticals, Inc.

Jul 14, 2015, 12:34 ET